Sign up to save your podcasts
Or
Share Enovis makes a $840M acquisition, Vicarious Surgical faces NYSE delisting
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Enovis makes a $840M acquisition, Vicarious Surgical faces NYSE delisting
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, September 26, 2023.
Check out the show notes for links to the stories we discuss today at MassDevice.com/podcast.
A new study has backed Attune Medical's esophagus-protecting device. Fast Five hosts Sean Whooley and Danielle Kirsh explain the technology and the regulatory backing behind it.
Surgical robotics are in the news again. USMI is set to debut its Canady surgical robot. Find out what the robot does and what executives are saying.
Dexcom has signed a partnership with RxFood to focus on AI-based nutrition and glucose monitoring for diabetes management. Whooley explains the goal behind the partnership and how they plan to accomplish their goal.
Vicarious Surgical is facing an NYSE delisting. The Fast Five hosts detail what the delisting notice said and what steps Vicarious can take to rectify the problem.
Enovis this week announced plans to acquire LimaCorporate for more than $840 million. Hear what LimaCorporate does and how this acquisition supplements Enovis' portfolio.
View all episodes
By MassDeviceWelcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, September 26, 2023.
Check out the show notes for links to the stories we discuss today at MassDevice.com/podcast.
A new study has backed Attune Medical's esophagus-protecting device. Fast Five hosts Sean Whooley and Danielle Kirsh explain the technology and the regulatory backing behind it.
Surgical robotics are in the news again. USMI is set to debut its Canady surgical robot. Find out what the robot does and what executives are saying.
Dexcom has signed a partnership with RxFood to focus on AI-based nutrition and glucose monitoring for diabetes management. Whooley explains the goal behind the partnership and how they plan to accomplish their goal.
Vicarious Surgical is facing an NYSE delisting. The Fast Five hosts detail what the delisting notice said and what steps Vicarious can take to rectify the problem.
Enovis this week announced plans to acquire LimaCorporate for more than $840 million. Hear what LimaCorporate does and how this acquisition supplements Enovis' portfolio.